| Date | Speaker | Title | Time starts | Duration |
| November 2015 | Chris Kosmidis | Isavuconazole: a new antifungal drug | 0’00’00secs | 0’36’40secs |
| Graham Atherton | Patients and carers disucssion | 0’36’40secs | end | |
| Led by Graham Atherton | Entire meeting (alternate version) |
We had to switch off the discussion with patients after Chris & Graham’s introduction ending at 36min 40sec as the group had to proceed privately. The slides discussed give a good deal of the information we talked about so are well worth reading once the talking has stopped.
Resources mentioned:
Share this post
Latest News posts
UK National RSV vaccination program launched
July 26, 2024
English prescription charge to rise 1st May 2024
April 26, 2024
The Role of Speech & Language Therapy (SALT)
April 16, 2024
Understanding How Our Lungs Fight Fungus
April 15, 2024
Chronic illness diagnosis and guilt
April 12, 2024
Chronic illness diagnosis and grief
April 11, 2024
ABPA guidelines update 2024
April 11, 2024
Salbutamol nebuliser solution shortage
March 25, 2024
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video